Back to Screener

Bruker Corporation (BRKR)

Price$56.39
Value ScoreD
Growth ScoreD
Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)7.60%
Price vs S&P 500 (4W)27.70%
VGM Score46.56
Market Capitalization$8.58B
Indicated Dividend Yield (Annual)0.33%

All Metrics

P/CF (Annual)63.87x
Book Value / Share (Quarterly)$16.09
P/TBV (Annual)4.60x
Indicated Dividend (Annual)$0.20
Revenue Growth (3Y)10.74%
Cash Flow / Share (Quarterly)$0.15
Payout Ratio (TTM)91.25%
Price vs S&P 500 (YTD)11.54%
Gross Margin (TTM)46.70%
Net Profit Margin (TTM)-0.34%
EPS (TTM)$-0.08
10-Day Avg Trading Volume3.74M
EPS Excl Extra (TTM)$-0.08
Revenue Growth (5Y)11.57%
EPS (Annual)$-0.06
Dividend / Share (Annual)$0.22
ROI (Annual)-0.20%
Gross Margin (Annual)47.13%
Net Profit Margin (5Y Avg)8.14%
Cash / Share (Quarterly)$0.88
Revenue Growth QoQ (YoY)2.75%
ROA (Last FY)-0.14%
Revenue Growth TTM (YoY)0.36%
EBITD / Share (TTM)$1.68
ROE (5Y Avg)17.91%
Operating Margin (TTM)0.81%
Cash Flow / Share (Annual)$0.09
P/B Ratio3.50x
P/B Ratio (Quarterly)2.25x
Net Income / Employee (Annual)$-800
EV / Revenue (TTM)2.93x
Net Interest Coverage (TTM)1.75x
ROA (TTM)-0.18%
EPS Growth QoQ (YoY)-17.64%
EV / EBITDA (TTM)39.52x
EPS Incl Extra (Annual)$-0.06
Current Ratio (Annual)1.73x
Quick Ratio (Quarterly)0.69x
3-Month Avg Trading Volume2.43M
52-Week Price Return49.62%
EV / Free Cash Flow (Annual)712.81x
Revenue / Employee (TTM)$312,000
Tangible BV / Share (Quarterly)$10.16
P/S Ratio (Annual)2.50x
Asset Turnover (Annual)0.55x
52-Week High$64.54
Operating Margin (5Y Avg)12.22%
EPS Excl Extra (Annual)$-0.06
CapEx CAGR (5Y)4.34%
Tangible BV CAGR (5Y)16.29%
26-Week Price Return15.53%
Quick Ratio (Annual)0.85x
13-Week Price Return46.47%
Total Debt / Equity (Annual)0.76x
Current Ratio (Quarterly)1.55x
Enterprise Value$10.12B
Revenue / Share Growth (5Y)11.98%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)20.62%
Revenue / Employee (Annual)$310,000
Inventory Turnover (Annual)1.68x
Pretax Margin (Annual)0.64%
Cash / Share (Annual)$1.96
3-Month Return Std Dev61.34%
Gross Margin (5Y Avg)49.86%
Net Income / Employee (TTM)$-1,000
EBITDA CAGR (5Y)-3.97%
EBITDA Interim CAGR (5Y)-9.43%
ROE (Last FY)-0.35%
Net Interest Coverage (Annual)1.71x
EPS Basic Excl Extra (Annual)$-0.06
P/FCF (TTM)38.13x
Receivables Turnover (TTM)5.34x
EV / Free Cash Flow (TTM)455.94x
Total Debt / Equity (Quarterly)0.68x
EPS Incl Extra (TTM)$-0.08
Receivables Turnover (Annual)5.22x
ROI (TTM)-0.27%
Dividend Growth Rate (5Y)6.15%
P/S Ratio (TTM)2.48x
Pretax Margin (5Y Avg)11.56%
Revenue / Share (Annual)$22.64
Tangible BV / Share (Annual)$10.23
Forward P/E26.36x
Free OCF CAGR (5Y)-42.95%
Price vs S&P 500 (52W)25.25%
Year-to-Date Return19.70%
5-Day Price Return-3.51%
EPS Normalized (Annual)$-0.06
ROA (5Y Avg)5.53%
Net Profit Margin (Annual)-0.25%
Month-to-Date Return-4.25%
Cash Flow / Share (TTM)$2.86
EBITD / Share (Annual)$1.77
Operating Margin (Annual)1.40%
LT Debt / Equity (Annual)0.75x
P/CF (TTM)61.05x
ROI (5Y Avg)8.60%
LT Debt / Equity (Quarterly)0.68x
EPS Basic Excl Extra (TTM)$-0.08
P/TBV (Quarterly)3.55x
Payout Ratio (Annual)26.70%
P/B Ratio (Annual)2.91x
Dividend / Share (TTM)$0.29
Inventory Turnover (TTM)1.62x
Pretax Margin (TTM)0.54%
Book Value / Share (Annual)$16.15
Price vs S&P 500 (13W)38.21%
Dividend Yield (TTM)0.51%
Beta1.29x
P/FCF (Annual)604.51x
Revenue / Share (TTM)$22.65
ROE (TTM)-0.51%
52-Week Low$28.53
vGradeD
gGradeD
mGradeB
vgmGradeC
Show chart for

Earnings Surprise History

Q1 260.31est. 0.24

Analyst Recommendations

Mar 2026
Apr 2026
May 2026
Jun 2026
3.95
3.95
3.91
3.91

Industry Peers — Lab Analytical Instruments(24)

About

Bruker Corporation manufactures scientific instruments and diagnostic tests serving the life sciences, pharmaceutical, and biotechnology industries. The company operates through multiple segments, including BioSpin, CALID, and Nano divisions, with CALID generating the largest revenue contribution. The majority of its revenue is derived from the United States market.